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Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide. It may result in several types of liver problems, including impaired liver regeneration (LR), but the mechanism for this is unknown. Because LR depends on calcium signaling, we examined the effects of NAFLD on expression of the type II inositol 1,4,5-trisphosphate receptor (ITPR2), the principle calcium release channel in hepatocytes. ITPR2 promoter activity was measured in Huh7 and HepG2 cells. ITPR2 and c-Jun protein levels were evaluated in Huh7 cells, in liver tissue from a rat model of NAFLD, and in liver biopsy specimens of patients with simple steatosis and nonalcoholic steatohepatitis (NASH). LR was assessed in wild-type and Itpr2 knockout (Itpr2 -/-) mice following 67% hepatectomy. Cell proliferation was examined in ITPR2-knockout HepG2 cells generated by the CRISPR/Cas9 system. c-Jun dose dependently decreased activity of the human ITPR2 promoter. c-Jun expression was increased and ITPR2 was decreased in fat-loaded Huh7 cells and in livers of rats fed a high-fat, high-fructose diet. Overexpression of c-Jun reduced protein and mRNA expression of ITPR2 in Huh7 cells, whereas knockdown of c-Jun prevented the decrease of ITPR2 in fat-loaded Huh7 cells. ITPR2 expression was decreased and c-Jun was increased in liver biopsies of patients with steatosis and NASH compared to controls. ITPR2-knockout cells exhibited less nuclear calcium signaling and cell proliferation than control cells. LR assessed by Ki-67 and proliferating cell nuclear antigen was markedly decreased in Itpr2 N onalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, affecting over half a billion people. (1) Although the majority of NAFLD patients have simple steatosis (SS), a subset of patients has nonalcoholic steatohepatitis (NASH), and 20% of NASH patients develop cirrhosis. In addition, NAFLD is associated with increased risk of hepatocellular carcinoma (HCC), the second-most common cause of cancer death. NAFLD also results in other specific liver problems, including impaired liver regeneration (LR). (2, 3) Although weight loss (4) and exercise (5) can be beneficial in NASH, the value of pharmacological treatments is less established. (6) Therefore, an improved Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AP-1, activator protein-1; ATP, adenosine triphosphate; bp, base pairs; BrdU, 5-bromo-2 0 -deoxyuridine; BSA, bovine serum albumin; EdU, 5-ethynyl-2 0 -deoxyuridine; EGF, epidermal growth factor; HCC, hepatocellular carcinoma; H&E, hematoxylin-eosin; HFFD, high-fat, high-fructose diet; HGF, hepatocyte growth factor; IACUC, Institutional Animal Care and Use Committee; Il-6, interleukin-6; ITPR, inositol 1,4,5-trisphosphate receptor; ITPR1, type I inositol 1,4,5-trisphosphate receptor; ITPR2, type II inositol 1,4,5-trisphosphate receptor; JNK, c-Jun NH 2 -terminal kinase; KO, knockout; LR, liver regeneration; MDA, malondialdehyde; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; PCNA, proliferating cell nuclear antigen; PH, partial hepatectomy; siRNA, small interfering RNA; SS, simple steatosis; TNF-a, tumor necrosis factor-alpha; WT, wild-type.
understanding of mechanisms responsible for the pathological consequences of NAFLD/NASH is a high priority.
Calcium (Ca 21 ) is a ubiquitous second messenger that regulates a wide range of functions in hepatocytes, including glucose (7) and lipid metabolism, (8) apoptosis, (9) gene transcription, (10) bile secretion, (11, 12) and cell proliferation. (13) Ca 21 signaling results from activation of the inositol 1,4,5-trisphosphate receptor (ITPR), and the type II inositol 1,4,5-trisphosphate receptor (ITPR2) is the principal intracellular calcium release channel in hepatocytes. (14) ITPR may be particularly important in lipid homeostasis, because Drosophila with Itpr mutations become obese and store excess triglycerides in their fat bodies even on a normal diet. (15) The type I inositol 1,4,5-trisphosphate receptor (ITPR1) may be more important than ITPR2 in regulating mammalian hepatic lipid metabolism, because ITPR1 selectively couples to mitochondria and regulates lipid droplet formation, and liver-specific Itpr1 -/-mice are resistant to NAFLD, (8) whereas Itpr2 -/-mice have no change in lipid metabolism. (16) However, interestingly, hepatic ITPR2 expression is decreased in obese mice, (16) but the mechanism of this and its pathophysiological relevance are unknown.
Materials and Methods

ANIMAL MODELS
Eight-week-old male Sprague-Dawley rats (180-200 g) were obtained from the National Laboratory Animal Center, Mahidol University (Bangkok, Thailand). After the acclimatization period, rats were assigned to receive either control diet (10% kcal as fat; Envigo, Cambridgeshire, UK)) with reverse osmosis water or high-fat diet (60% kcal as fat; Envigo) with 30% (w/v) fructose in water for 12 weeks to develop NAFLD model.
The whole-body homozygous knockout Itpr2 -/-mice in a C57BL/6 genetic background were used in this study. Nine-to 10-week-old male Itpr2 -/-and their wild-type (WT) littermates underwent sham laparotomy or two-thirds hepatectomy as described. (17) All animals received humane care in accord with the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the National Institutes of Health, and all study procedures were approved by the Institutional Animal Care and Use Committee. The study protocol for rats challenged with high-fat, highfructose diet (HFFD) was approved by the Institutional Animal Care and Use Committee (IACUC) of Faculty of Science, Mahidol University. The study protocol for Itpr2 -/-mice was approved by Yale's IACUC.
GENERATION OF AN ITPR2-KNOCKOUT HepG2 CELL LINE
An ITPR2-knockout HepG2 cell line was established using the CRISPR/Cas9 system. Control CRISPR/Cas9 plasmid, a nontargeting 20-nucleotide scramble guide RNA designed as a negative control, IP3R-II CRISPR/Cas9 KO plasmid, and IP3R-II HDR plasmid were obtained from Santa Cruz Biotechnology (Dallas, TX, USA). Successful deletion of ITPR2 was confirmed by immunoblotting.
ARTICLE INFORMATION:
NUCLEAR CALCIUM IMAGING ITPR2 CRISPR-knockout or CRISPR-control HepG2 cells were plated onto coverslips and transfected with a nuclear targeted calcium-sensing protein, GCaMP3 plasmid (a gift from Dr. Anant Parekh, University of Oxford). Transfected nuclear-GCaMP3 cells were perfused with a HEPES buffer while stimulated with 20 lM of adenosine triphosphate (ATP). This ATP concentration was used because it is sufficient to elicit nuclear Ca 21 signals in this cell type. (18) Ca 21 signaling in the cell nucleus was monitored using a Zeiss 710 confocal microscope as described. 
STATISTICAL ANALYSIS
All data are expressed as means 6 SEM. GraphPad Prism 7 Software was used for data analysis. Statistical analyses were performed using the Student t test or the one-way analysis of variance. Differences with P < 0.05 were considered statistically significant.
FURTHER METHODOLOGICAL DETAILS
Detailed additional Materials and Methods are available in the Supporting Information.
Results
ITPR2 IN HEPATOCYTES IS TRANSCRIPTIONALLY REGULATED BY c-Jun
The transcription factor, c-Jun, is often elevated in inflammation, including in NAFLD. (19) We recently cloned the human ITPR2 promoter and found that it contained at least one activator protein-1 (AP-1)/c-Jun binding site. 
STEATOSIS INHIBITS ITPR2 EXPRESSION THROUGH c-Jun IN VITRO
To investigate whether effects of c-Jun on ITPR2 expression are relevant in steatosis, we examined Huh7 cells loaded with palmitic acid to mimic fat accumulation in the liver. Palmitic acid-treated Huh7 cells exhibited a marked increase in fat deposition compared to bovine serum albumin (BSA)-treated Huh7 cells as a control group ( Fig. 2A) . Expression of c-Jun was significantly increased and ITPR2 expression was significantly decreased in fat-loaded Huh7 cells (Fig. 2B,C) . To investigate whether this was a causal relationship, small interfering RNA (siRNA) was used to knock down c-Jun in Huh7 cells. Loss of c-Jun did not affect ITPR2 expression in control cells, but the palmitic acid-induced decrease in ITPR2 was abolished by knockdown of c-Jun (Fig. 2D,E ). These findings provide evidence that steatosis decreases ITPR2 expression in liver cells, and that is mediated by c-Jun.
c-Jun IS INCREASED AND ITPR2 EXPRESSION IS DECREASED IN LIVERS OF NAFLD RATS
To investigate the relevance of these findings in vivo, rats were fed an HFFD to mimic human NAFLD. HFFD-fed rats developed features of hepatic steatosis that included an accumulation of lipid droplets in the hepatocytes (Supporting Fig. S2A ,B) and elevated liver triglyceride levels (Supporting Fig.  S2C ). These rats also developed liver damage, as reflected by increased serum levels of alanine aminotransferase (ALT; Supporting Fig. S2D ) and alkaline phosphatase (ALP; Supporting Fig. S2E ), relative to control diet-fed rats. Oxidative stress and inflammation that occurs in NAFLD condition can increase cJun, (21) so we also measured hepatic malondialdehyde (MDA), interleukin-6 (Il-6), and tumor necrosis factor-alpha (Tnf-a) mRNA levels. Both the oxidative stress marker, MDA (Supporting Fig. S2F ), and the inflammatory cytokines, Il-6 (Supporting Fig. S2G ) and Tnf-a (Supporting Fig. S2H ), were increased significantly in HFFD-fed rats, relative to control dietfed rats. This observation demonstrates that this particular animal model of NAFLD is associated with steatosis, mild hepatitis, and associated increases in hepatic inflammatory markers. We also investigated the effects of NAFLD on c-Jun and ITPR2 expression in this animal model (Fig. 3) . Expression of c-Jun was significantly increased (Fig. 3A) , whereas ITPR2 expression was significantly decreased (Fig. 3B) , in livers of HFFD-fed rats. In contrast, ITPR1 expression was unchanged (Fig. 3C) . This is consistent with the recent observation that ITPR1 expression is unchanged in liver biopsies from patients with SS. (8) Although this isoform is increased in patients with NASH, (8) levels of ITPR1 remained unchanged in HFFD-fed rats (Fig. 3C) . Finally, we examined the cJun NH 2 -terminal kinase (JNK) pathway, which is activated by oxidative stress and regulates c-Jun expression. Phospho-JNK was increased in HFFD-fed rats (Fig. 3D) , consistent with its role as an intermediary in elevating c-Jun. Together, these findings support the idea that NAFLD leads to hepatic inflammation, which, in turn, results in a JNK-and c-Jun-mediated decrease in hepatic ITPR2 expression in an animal model.
c-Jun IS INCREASED AND ITPR2 EXPRESSION IS DECREASED IN LIVERS OF PATIENTS WITH NAFLD
To investigate the clinical relevance of these observations, we examined liver biopsies from patients with SS and NASH, plus histologically normal biopsies. Histological diagnoses were established based on examination of hematoxylin-eosin (H&E) staining of the specimens (Fig. 4A) . Immunohistochemistry of these liver sections demonstrated that c-Jun expression in hepatocytes was low in normal biopsies, but was markedly and significantly increased in patients with steatosis or NASH (Fig. 4B,D) . Moreover, c-Jun was localized to the nuclei of hepatocytes and to infiltrating inflammatory cells in the NAFLD specimens. In contrast, ITPR2 was expressed in normal human liver and was most concentrated in the pericanalicular region (Fig. 4C) , similar to what is observed in rodent livers. (14, 22) Furthermore, ITPR2 expression was significantly decreased or absent in steatosis and NASH (Fig. 4C,E) . These findings are consistent with our observations in vitro and in an animal model that NAFLD leads to a c-Jun-mediated loss of ITPR2 in hepatocytes.
LOSS OF ITPR2 IMPAIRS LR
Finally, we investigated the potential pathophysiological relevance of loss of ITPR2. Calcium signaling is important for hepatocyte proliferation (13) and LR, (7, 9, 23) and LR is impaired in NAFLD, (2, 24, 25) so we examined LR in Itpr2 -/-mice. Male WT and Itpr2 -/-mice that were 9-10 weeks of age were subjected to partial hepatectomy (PH). Histological examination 48 hours postoperatively revealed liver damage and necrosis in the Itpr2 -/-, but not in the WT mice (Fig. 5A-D) . The posthepatectomy Itpr2 -/-livers were notable for diffuse steatosis, plus patchy but welldemarcated necrotic areas. The patchy necrosis was coagulative, randomly rather than zonally distributed across the hepatic lobule, and showed no signs of cholestasis. Moreover, in the necrotic areas, cell borders remained visible, and the cytoplasm and nuclei were in varying stages of disintegration, but were not swollen. There was scant neutrophilic inflammation in these foci, without macrophages, fibrosis, feathery degeneration, or bile pigment deposition. These changes are not characteristic of bile infarcts, unlike what is observed post-PH in TGR5- (26) or P2X4-knockout mice. (27) In addition, LR assessed by either Ki-67 (Fig. 5E ) or proliferating cell nuclear antigen (PCNA; Fig. 5F ) labeling revealed a marked decrease in Itpr2 -/-mice relative to WT mice.
As typical immediate early genes, c-Jun and c-Fos are rapidly induced post-PH. (23) To investigate whether ITPR2 expression is inversely correlated with c-Jun and c-Fos soon post-PH, we measured hepatic mRNA expression of Itpr-2, c-Jun, and c-Fos at 1 and 2 hours post-PH in C57BL/6 mice (Fig. 6) . At both of these early time points post-PH, hepatic mRNA levels of c-Jun and c-Fos were markedly increased, whereas Itpr2 was significantly decreased 2 hours post-PH (Fig. 6D ). This observation is consistent with the idea that increased c-Jun is an early event that is responsible for decreased ITPR2 expression post-PH. (28) NUCLEAR Ca 21 
SIGNALING AND CELL PROLIFERATION DEPEND ON ITPR2 IN HepG2 CELLS
Because nucleoplasmic calcium is required for cell proliferation (13) and ITPR2 is the most abundant ITPR isoform in hepatocytes, (14) we examined whether deletion of ITPR2 affects nuclear Ca 21 signaling and cell proliferation. ITPR2-knockout (KO) HepG2 cells were generated using the CRISPR/Cas9 system, then transfected with nuclear targeted calcium-sensing protein (GCaMP3). (29) Nuclear Ca 21 signals were monitored in cells stimulated with ATP, because ATP induces Ca 21 signals in the nucleus of HepG2 cells, (18) and because ATP serves as a paracrine messenger that regulates LR. (30, 31) Absence of ITPR2 in ITPR2-CRISPR-KO cells was verified (Fig. 7A) (Fig. 7B) . Similarly, the fraction of ITPR2-CRISPR-KO cells in which ATP induced a nuclear Ca 21 signal was markedly and significantly lower than that of control cells (Fig. 7C) . This result supports the idea that ITPR2 regulates nuclear Ca 21 signaling. Two different assays were used to determine the relevance of ITPR2 for hepatocyte proliferation. The 5-bromo-2 0 -deoxyuridine (BrdU)/enzyme-linked immunosorbent assay was performed in ITPR2-CRISPR-KO and control cells 24 and 48 hours after addition of serum, and showed that proliferation was decreased by 50% at both time points (Fig. 7D,E) . Similarly, 5-ethynyl-2 0 -deoxyuridine (EdU) imaging showed that proliferation of ITPR2-CRISPR-KO cells was decreased by nearly 70% relative to controls 24 hours after addition of serum (Fig. 8) . These observations provide evidence that ITPR2 is important for LR because it mediates nuclear Ca 21 signaling, which, in turn, is necessary for cell proliferation.
Discussion
Altered calcium signaling has been implicated in the pathogenesis of a range of liver diseases, including cholestasis, (11, 12) NAFLD, (8) and HCC. (13) These disparate effects of calcium are likely because there is differential control of calcium signals in distinct subcellular regions. For example, pericanalicular calcium signals regulate secretion, (11, 12) mitochondrial calcium signals regulate lipid droplet formation, (8) and nuclear calcium signals regulate cell proliferation. (13) Subcellular regulation of calcium signals in turn is attributed, at least in part, to the subcellular distribution of different ITPR isoforms. ITPR2, which accounts for approximately 80% of ITPRs in hepatocytes, is most heavily concentrated in the region of the endoplasmic reticulum beneath the canalicular membrane, (14, 22) and loss of this pool results in cholestasis. (11, 12) Although ITPR1 accounts for only approximately 20% of ITPRs in hepatocytes, this isoform selectively couples to mitochondria, and so it plays a role in lipid droplet formation and its increased expression is associated with development of NAFLD. (8) There is also specificity in these effects, because loss of ITPR2 does not affect basal lipid metabolism, (16) whereas loss of ITPR1 does not affect secretion. (8) Our findings provide evidence, however, that NAFLD affects ITPR2 expression, and that cell proliferation is a previously unappreciated target of ITPR2-mediated calcium signals. Given the implications of these findings for the impaired LR that is known to occur in NAFLD, (2, 24, 25) the factors that regulate ITPR2 expression are of potential clinical importance. Both nuclear factor of activated T cells (32) and cAMP/cAMP responsive element-binding protein increase ITPR2 transcription. (20) In fact, ITPR2 expression is increased during fasting, which may be mediated by glucagon-induced increases in cAMP. (20) Inhibition of ITPR2 expression by miRNA-133a has been described in cardiomyocytes, (33) and the current study reports on transcription factor-mediated inhibition of ITPR2 expression.
It is appreciated that Ca 21 signaling is important for LR, but the current work extends our understanding of this relationship in an important way. Previous work had established that cytosolic, (23) nuclear, (13) and mitochondrial (9) Ca 21 signals each contribute in separate ways to hepatocyte proliferation and LR. Furthermore, it had been shown that cytosolic Ca 21 signals and ITPR2 expression, in particular, are decreased post-PH, (28) and the current work provides evidence that these are mediated by an increase in c-Jun that occurs very early posthepatectomy (Fig. 6) . However, ITPR2 expression typically is reduced by only 30%-50% post-PH, and Ca 21 signals, while reduced, are not absent . (28) Combined with the previous observation that hepatocyte Ca 21 signals are largely abolished in the absence of ITPR2, (8) (26) and P2X4, (27) also result in impaired LR, and in the relevant knockout animals there is evidence for bile infarcts in the periportal region of regenerating livers. In contrast, in regenerating livers of Itpr2 -/-mice there is patchy necrosis that does not resemble bile infarcts and is not distributed in a lobular pattern (Fig. 5) . This suggests that the impaired LR observed in Itpr2 -/-mice is not attributed to biliary defects, which is not surprising because ITPR2 represents a minor fraction of the total ITPR pool in cholangiocytes, (34) and loss of ITPR2 from cholangiocytes has only a mild inhibitory effect on secretion. (35) The relationship between fatty liver, ITPR2, and LR that is described here suggests an unexpected link. It has long been appreciated that fatty liver is associated with impaired LR, which is clinically relevant because patients with NAFLD have increased mortality following liver resection.
(2) Although a number of responsible mechanisms have been proposed, (24, 25) the current observation may suggest a more fundamental explanation. AP-1/c-Jun is a well-known mediator of inflammation, and LR is thought to be more significantly impaired in NASH than in SS.
(2) The current work identifies AP-1/c-Jun as a negative transcriptional regulator of ITPR2 expression and provides evidence that one specific effect of fatty liver is to decrease ITPR2 expression through this mechanism. Although ITPR2 is most concentrated in the pericanalicular region of the cytosol, where it regulates multidrug resistance-associated protein-2 (12) and bile salt export pump, (11) it also is found in the nucleus, (18, 36) where it is positioned to regulate calcium-mediated intranuclear processes. Furthermore, nuclear ITPRs are selectively activated by growth factors such as hepatocyte growth factor (HGF), (37) epidermal growth factor (EGF), (38) and insulin, (7) which are specifically responsible for the calcium signals in the nucleus that regulate cell proliferation. (7, 13, 37) Moreover, LR is impaired in the absence of either HGF (39) or EGF, (40) and outright liver failure occurs if both of these growth factors are absent. (41) Therefore, the subpopulation of ITPR2 localized to the nucleus may participate in a final common pathway that permits growth factors to elicit the calcium signals in the nucleus that are necessary for LR. Indeed, the current work demonstrates that nuclear Ca 21 -signals depend on ITPR2, and that hepatocyte proliferation, which depends on nuclear Ca 21 signals, (13) also depends on ITPR2 (Figs. 7 and 8) . This, in turn, may explain why NAFLD, by increasing c-Jun and thus decreasing ITPR2, results in impaired LR. Further work will be needed to confirm the relative importance of this mechanism in patients with NAFLD and to determine whether this pathway can be exploited for therapeutic benefit.
